Justin Keywood

Justin Keywood is an analyst at Stifel who covers HLS Therapeutics Inc. He recently adjusted his target for the company while maintaining a hold rating, noting the challenges in meeting growth targets and the potential impact of share buybacks on stock performance amid limited liquidity.